Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05417854 · ClinicalTrials.gov registry record · NA
Ultrasound Treatment for Rheumatoid Arthritis Study [ULTRA Study]
A NA study, sponsored by SecondWave Systems.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT05417854: Completed NA study, sponsored by SecondWave Systems.
NCT05417854 is a NA study that has completed, run by SecondWave Systems. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05417854, a NA study, has completed, sponsored by SecondWave Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The research objective is to assess efficacy of spleen ultrasound stimulation in the treatment of rheumatoid arthritis (RA) in a pilot study. Specific Aims: * Measure RA disease activity and clinical metrics during and after an 8-week course of spleen-directed daily ultrasound treatments. * Measure molecular correlates, including Erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), cortisol and cytokine levels, of rheumatoid arthritis disease activity during spleen-directed daily ultrasound treatments.
Primary Outcome
A decrease in Disease Activity Score indicates an improved outcome.
Interventions
- DEVICE Splenic Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2022-06-29 |
| Est. Completion | 2023-09-25 |
| Phase | NA |
What the finished NCT05417854 record still lists
NCT05417854 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Splenic Ultrasound is the first listed.
NCT05417854 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05417854 about?
NCT05417854 is a clinical study titled "Ultrasound Treatment for Rheumatoid Arthritis Study [ULTRA Study]". The research objective is to assess efficacy of spleen ultrasound stimulation in the treatment of rheumatoid arthritis (RA) in a pilot study. Specific Aims: * Measure RA disease activity and clinical metrics during and after an 8-week course of spleen-directed daily ultrasound treatments. * Measur...
What is the current status of trial NCT05417854?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2022-06-29. Estimated completion is 2023-09-25.
What interventions are being tested in trial NCT05417854?
The interventions under investigation include: Splenic Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT05417854?
This trial is sponsored by SecondWave Systems, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05417854's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy